[Performing Duties This Year] National People's Congress Deputy Li Zhenguo: Fulfilling Responsibilities on the Frontline of COVID-19 Response


2020-05-18

China Food and Drug News (Reporter: Luo Nan) — Employees remain "zero infections," the company has donated over 2 million yuan worth of supplies, more than 300 pharmacies continue operating as usual, and production facilities are working full throttle to ensure a steady supply of medicines. In the nationwide battle against the COVID-19 pandemic, Li Zhenguo, a deputy to the National People's Congress and Chairman of Jiuzhitang Co., Ltd., has led his company to leverage its strengths and do everything possible, mobilizing resources across the entire pharmaceutical value chain—from manufacturing to distribution—in the fight against the virus.

"When the fight against the pandemic calls, Jiuzhitang cannot be absent," said Representative Li Zhenguo. As a pharmaceutical company with a 370-year history of traditional Chinese medicine development, Jiuzhitang upholds the philosophy that "a pharmacist must dedicate their full effort, and a physician should always act with integrity." Therefore, Jiuzhitang should actively embrace its social responsibility.

For the average person, staying out of trouble is itself a contribution to fighting the epidemic. During this critical time, Jiuzhitang mobilized its branches and subsidiaries across the country, urging each company to strictly follow local government guidelines and meticulously implement comprehensive epidemic prevention and control measures—resulting in "zero infections" among all employees.

The pharmacy right outside people’s doors serves as a vital gateway for residents to access personal protective products. During the epidemic prevention and control period, more than 300 chain pharmacies under Jiuzhitang remained open, offering health consultations and medication guidance to local residents. They also made every effort to ensure the availability of essential products needed for pandemic response, with select stores even arranging regular, free distribution of masks—totaling over 10,000 masks handed out to the community.

To support frontline efforts in fighting the epidemic, Jiuzhitang has taken two key actions: first, accelerating the resumption of production and operations to ensure a steady supply of medicines; second, donating funds and medical supplies to bolster the fight against the virus. Immediately after the outbreak, Jiuzhitang issued an urgent mobilization order across all its production facilities. By February 10, all bases had fully resumed work, working tirelessly to maintain robust pharmaceutical production and supply. In addition to supporting the "epidemic battle," Jiuzhitang donated essential items such as medicines, masks, and disinfectants to organizations including the Zhong Nanshan Medical Foundation, the Tianjin Red Cross Society, and the Hunan Red Cross Society—totaling over 2 million yuan worth of donations in both materials and financial contributions.

The positive role played by Traditional Chinese Medicine (TCM) in this epidemic response has firmly strengthened Representative Li Zhenguo’s confidence in leading Jiuzhitang to carry forward and develop the TCM cause. "TCM has proven effective in alleviating disease symptoms, improving recovery rates, reducing mortality, and accelerating physical rehabilitation among patients in the recovery phase—findings that have been clinically validated, truly inspiring everyone involved in TCM!" said Representative Li Zhenguo. He added that while China has now entered a new normal of epidemic prevention and control, the global situation remains severe. As a TCM enterprise, Jiuzhitang will continue its efforts in fighting the pandemic while simultaneously promoting TCM culture and intensifying research and development of its product portfolio, taking concrete actions to help TCM go global.